15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB
The current study demonstrates a steady improvement in treatment outcomes for DR-TB after a long period of stagnation. However, new drugs and novel regimens are needed to maintain or further improve treatment outcomes in DR-TB.
Authors
- Mohammad Javad Nasiri (ORCID: https://orcid.org/0000-0002-3279-0671)
- Tessa M. Hill (ORCID: https://orcid.org/0000-0003-4159-9104)
- Saba Gidey
- Hardik Gandhi (ORCID: https://orcid.org/0000-0001-8274-828X)
- Lia D’Ambrosio (ORCID: https://orcid.org/0000-0002-7000-5777)
- Rosella Centis (ORCID: https://orcid.org/0000-0002-8551-3598)
- D. R. Silva
- Masoud Dara (ORCID: https://orcid.org/0000-0003-0025-6607)
- Giovanni Sotgiu (ORCID: https://orcid.org/0000-0002-1600-4474)
- Mahdis Cheraghi
- Karam Diaby
- Norbert Hittel
- Maryam Amiri (ORCID: https://orcid.org/0000-0001-5246-6951)
- Maia Mileva-Lopez
Institutions
- Pharmaceutical Product Development (United States) (US)
- Universidade Federal do Rio Grande do Sul (BR)
- University of Sassari (IT)
- Otsuka (United States) (US)
- Istituti Clinici Scientifici Maugeri (IT)
- Novel (Germany) (DE)
- Otsuka (Germany) (DE)
- Shahid Beheshti University of Medical Sciences (IR)
Publication Details
- Journal
- IJTLD OPEN
- Published
- 2025-04-01
- DOI
- https://doi.org/10.5588/ijtldopen.24.0620
- Citations
- 3
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 4.19